Live feed
Filing
SC 13G
SC 13G0001104659-21-020676·Inhibikase Therapeutics, Inc.
Schedule 13G ownership disclosure
INHIBIKASE THERAPEUTICS INC
Security class unavailable · CUSIP: 45719W106
Event date: 2020-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 53.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-020676
- Form type
- SC 13G
- Filer
- Inhibikase Therapeutics, Inc.
- CIK
- CIK 1750149
- Filed
- Feb 11, 2021
- Reporting period
- Dec 22, 2020
- Description
- Schedule 13G beneficial ownership